Drugs / bone marrow aspirate concentrate
bone marrow aspirate concentrate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03372954 | Jan 2018 → Dec 2020 | heart failure | University Hospital Ostrava | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bone marrow aspirate concentrate | “application of bone marrow aspirate concentrate (BMAC) through coronary sinus in” NCT03372954 ↗ |
| Known as | BMAC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03372954 ↗ |
| Known as | Harvest BMAC | “The Harvest BMAC contains the entire population of nuclear cells from bone marrow aspirates together with platelets.” PMID 30704414 ↗ Jan 2019 |
| Modality | Cell therapy | “retrograde application of non-selected bone marrow autologous cells concentrate (BMAC)” NCT03372954 ↗ |
| Route | Other | “retrograde BMAC administration via coronary sinus” PMID 30704414 ↗ Jan 2019 |